- Home
- DBI vs PRQR Comparison
DBI vs PRQR Comparison
Compare DBI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- PRQR
- Stock Information
- Founded
- DBI 1991
- PRQR 2012
- Country
- DBI United States
- PRQR Netherlands
- Employees
- DBI N/A
- PRQR N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- PRQR Health Care
- Exchange
- DBI Nasdaq
- PRQR Nasdaq
- Market Cap
- DBI 292.2M
- PRQR 309.5M
- IPO Year
- DBI 1991
- PRQR 2014
- Fundamental
- Price
- DBI $5.80
- PRQR $3.54
- Analyst Decision
- DBI Hold
- PRQR Strong Buy
- Analyst Count
- DBI 3
- PRQR 4
- Target Price
- DBI $6.50
- PRQR $7.13
- AVG Volume (30 Days)
- DBI 1.9M
- PRQR 559.8K
- Earning Date
- DBI 12-10-2024
- PRQR 11-07-2024
- Dividend Yield
- DBI 3.49%
- PRQR N/A
- EPS Growth
- DBI N/A
- PRQR N/A
- EPS
- DBI N/A
- PRQR N/A
- Revenue
- DBI $3,059,173,000.00
- PRQR $20,506,357.00
- Revenue This Year
- DBI $0.78
- PRQR $370.31
- Revenue Next Year
- DBI $3.19
- PRQR N/A
- P/E Ratio
- DBI N/A
- PRQR N/A
- Revenue Growth
- DBI N/A
- PRQR 306.68
- 52 Week Low
- DBI $4.36
- PRQR $1.61
- 52 Week High
- DBI $11.57
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DBI 56.43
- PRQR 49.97
- Support Level
- DBI $4.76
- PRQR $3.45
- Resistance Level
- DBI $5.69
- PRQR $3.97
- Average True Range (ATR)
- DBI 0.41
- PRQR 0.20
- MACD
- DBI 0.16
- PRQR -0.06
- Stochastic Oscillator
- DBI 71.35
- PRQR 26.98
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.